Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.

@article{Stocchi2011EffectOR,
  title={Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.},
  author={Fabrizio Stocchi and José Martin Rabey},
  journal={European journal of neurology},
  year={2011},
  volume={18 12},
  pages={
          1373-8
        }
}
  • Fabrizio Stocchi, José Martin Rabey
  • Published 2011
  • Medicine
  • European journal of neurology
  • BACKGROUND The LARGO study demonstrated that rasagiline 1 mg/day as adjunct to levodopa significantly reduces OFF time to the same magnitude as adjunct entacapone. This substudy of LARGO aimed to assess the effect of rasagiline and entacapone on the motor symptoms of PD during the practically defined OFF state. METHODS LARGO was a randomized, double-blind, multicenter trial that assessed the efficacy and safety of rasagiline (1 mg/day), entacapone (200 mg with each levodopa dose), and placebo… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 33 CITATIONS, ESTIMATED 59% COVERAGE

    Rasagiline for the treatment of Parkinson’s disease: an update

    VIEW 3 EXCERPTS
    CITES BACKGROUND

    Open-Label Study of Sleep Disturbances in Patients with Parkinson's Disease Treated with Rasagiline.

    FILTER CITATIONS BY YEAR

    2012
    2020

    CITATION STATISTICS

    • 2 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 22 REFERENCES

    Levodopa and the progression of Parkinson's disease.

    VIEW 1 EXCERPT

    Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.

    VIEW 1 EXCERPT

    Quality of life in Parkinson's disease: the relative importance of the symptoms.

    VIEW 1 EXCERPT